Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Mission Fund was founded by Alex Blyth, a serial entrepreneur and inventor, to tackle the funding challenges faced by biotech companies developing potentially breakthrough cures. Established under Breakthrough Therapy Ventures Ltd, the fund collaborates with Oxford Technology Management and MedCity to provide essential resources for early-stage biotech ventures.
Currently, the fund focuses on supporting companies at the pre-seed, seed, and seed-plus stages, emphasizing the importance of proof-of-concept studies. The Mission Fund aims to bridge the funding gap for innovative therapeutic ideas, facilitating access to both financial support and expert guidance necessary for advancing these projects.
The Mission Fund invests primarily in biotech companies that are developing potentially curative therapies. Its investment strategy targets sectors such as biotech, healthcare, and longevity, with a particular emphasis on solid tumors, central nervous system (CNS) indications, and aging-related conditions.
Investment stages include pre-seed, seed, and seed-plus, with a focus on financing critical proof-of-concept studies. This approach allows the fund to support innovative treatments in oncology and mental health, ensuring that promising therapeutic ideas receive the necessary backing to prove their viability.
Alex Blyth - Managing Partner; a serial entrepreneur and inventor with extensive experience in biotech.
Mishel Marquez - Partner & Investor Relations Manager; responsible for managing investor relationships and communications.
Bill Liao - Investment Director; focuses on evaluating investment opportunities and managing the fund's portfolio.
Troy Aberle - Venture Partner; brings expertise in venture capital and biotech investments.
Sam Patel - Venture Partner; involved in sourcing and evaluating new investment opportunities.
Claus Bo Svendsen - Team Member; contributes to the fund's operational and strategic initiatives.
Srini Sundaram - Team Member; supports investment analysis and portfolio management.
Dr. Valentino Parravicini - Expert Review Team; provides scientific expertise in therapeutic evaluations.
Dr. Oxana Polyakova - Expert Review Team; specializes in biotech research and development.
Patrick Burgermeister - Expert Review Team; offers insights into clinical development processes.
Professor Stuart Jones - Expert Review Team; academic expert in oncology.
Professor Farzin Farzaneh - Expert Review Team; focuses on aging-related research.
Giuseppe Mazza - Expert Review Team; provides expertise in CNS-related therapies.
Professor John Campbell - Expert Review Team; specializes in mental health therapies.
Flor Bollini - Expert Review Team; contributes to evaluations of therapeutic innovations.
To pitch The Mission Fund, founders should visit their website and submit their proposals. It is recommended to include comprehensive details about the therapeutic approach, the stage of development, and any preliminary data supporting the project.
What are The Mission Fund's investment criteria?
The Mission Fund focuses on biotech companies developing potentially curative therapies, particularly in solid tumors, CNS indications, and aging-related conditions. They prioritize funding for proof-of-concept studies.
How can I pitch to The Mission Fund?
Founders can submit their pitches through the The Mission Fund website. It is advisable to include detailed information about the therapeutic approach and the stage of development.
What makes The Mission Fund different from other investors?
The Mission Fund specifically targets the funding gap for early-stage biotech companies by financing proof-of-concept studies, which is often a critical hurdle for startups in this sector.
What is the geographic scope of The Mission Fund?
The Mission Fund does not specify a geographic focus, but it collaborates with partners like Oxford Technology Management and MedCity, which are based in the UK.
What is the typical check size for investments?
Specific check sizes are not disclosed, but the fund primarily invests at the pre-seed, seed, and seed-plus stages, which typically involve smaller initial investments.
What kind of post-investment support does The Mission Fund provide?
The Mission Fund offers access to experts and resources to help companies advance their therapeutic ideas, although specific details on post-investment involvement are not provided.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.